Download FREE Report Sample
Download Free sampleSomatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin and Somatostatin Analogs Market contains market size and forecasts of Somatostatin and Somatostatin Analogs in global, including the following market information:
Global Somatostatin and Somatostatin Analogs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Somatostatin and Somatostatin Analogs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Somatostatin and Somatostatin Analogs companies in 2021 (%)
The global Somatostatin and Somatostatin Analogs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Octreotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Somatostatin and Somatostatin Analogs include Novartis, Pfizer, Ispen, HYBIO and TianTaiShan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Somatostatin and Somatostatin Analogs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Somatostatin and Somatostatin Analogs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Somatostatin and Somatostatin Analogs Market Segment Percentages, by Type, 2021 (%)
Octreotide
Lanreotide
Pasireotide
Other
Global Somatostatin and Somatostatin Analogs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Somatostatin and Somatostatin Analogs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Other
Global Somatostatin and Somatostatin Analogs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Somatostatin and Somatostatin Analogs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Somatostatin and Somatostatin Analogs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Somatostatin and Somatostatin Analogs revenues share in global market, 2021 (%)
Key companies Somatostatin and Somatostatin Analogs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Somatostatin and Somatostatin Analogs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Ispen
HYBIO
TianTaiShan
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
